Porex Surgical Group

Porex Surgical Group was a healthcare company focused on porous polyethylene surgical implants used in reconstructive, craniofacial, oculoplastic, ENT, and oral/maxillofacial procedures. The business was best known for the MEDPOR product family, a line of bioimplantable porous polyethylene implants designed to support tissue ingrowth and surgical reconstruction. Historical FDA records identify Porex Surgical Products Group as the applicant for MEDPOR implants, and Stryker later disclosed that it acquired the bioimplantable porous polyethylene product line from Porex Surgical in 2010. As a result, the original company/business is best understood today as an acquired and no longer independently active medical device entity rather than a standalone operating biotech or pharma company.